[Editor’s Note: This article was updated on 14 December with additional commentary from securities analysts that arrived after publication of the original version on 13 December.]
Integra LifeSciences has agreed to acquire Acclarent from Johnson & Johnson/Ethicon, adding Acclarent’s ear, nose, and throat surgery (ENT) product lines to the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?